2

METABOLIC EFFECTS OF HORMONE THERAPY IN TRANSGENDER PATIENTS

Year:
2016
Language:
english
File:
PDF, 435 KB
english, 2016
4

INSULIN DOSE REDUCTIONS IN THE INPATIENT SETTING: HOW MUCH IS ENOUGH?

Year:
2018
Language:
english
File:
PDF, 363 KB
english, 2018
6

Proteoglycan–LDL interactions: A novel therapeutic target?

Year:
2014
Language:
english
File:
PDF, 156 KB
english, 2014
11

Vascular proteoglycans and atherosclerosis: Not over yet

Year:
2014
Language:
english
File:
PDF, 168 KB
english, 2014
17

Ursolic acid effect on atherosclerosis: Apples and apples, or apples and oranges?

Year:
2011
Language:
english
File:
PDF, 74 KB
english, 2011
18

Animal models of atherosclerosis: More than mice

Year:
2010
Language:
english
File:
PDF, 78 KB
english, 2010
21

U-500: A Convenient Insulin for a Convenience Food Nation

Year:
2013
Language:
english
File:
PDF, 211 KB
english, 2013
23

Advances in the management of hyperlipidemia-induced atherosclerosis

Year:
2008
Language:
english
File:
PDF, 317 KB
english, 2008
27

Serum amyloid A in atherosclerosis

Year:
2011
Language:
english
File:
PDF, 140 KB
english, 2011
38

New-onset diabetes after transplantation: focus on treatment strategies

Year:
2011
Language:
english
File:
PDF, 1.21 MB
english, 2011
40

Role of Dyslipidemia in Patients With Chronic Kidney Disease

Year:
2013
Language:
english
File:
PDF, 378 KB
english, 2013
47

Management of Dyslipidemia in Patients After Solid Organ Transplantation

Year:
2008
Language:
english
File:
PDF, 831 KB
english, 2008